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Summary 
BACKGROUND: Part of the ReMINE project involved the creation of an ontology enabling 
computer-assisted decision support for optimal adverse event management. OBJECTIVES: 
The ontology had to satisfy the following requirements: (1) to be able to account for the 
distinct and context-dependent ways in which authoritative sources define the term ‘adverse 
event’, (2) to allow the identification of relevant RAPS information on the basis of the disease 
history of a patient as documented in electronic health records, and (3) to be compatible with 
present and future ontologies developed under the OBO Foundry framework. METHODS: 
We used as feeder ontologies the Basic Formal Ontology, the Foundational Model of 
Anatomy, the Ontology of General Medical Science, the Information Artifact Ontology and 
the Ontology of Mental Health. We further used relations defined according to the pattern set 
forth in the OBO Relation Ontology. In light of the use of the ontology for the representation 
of adverse events that actually occurred and therefore are registered in a database, we also 
applied the principles of Referent Tracking. RESULTS: We merged the upper portions of the 
feeder ontologies and introduced 22 additional representational units of which 13 are 
generally applicable in biomedicine and 9 in the adverse event context. We provided for each 
representational unit a textual definition that can be translated into equivalent formal 
definitions. CONCLUSION: The resulting ontology satisfies all requirements set forth. 
Merging the existing ontologies, although all designed under the OBO Foundry principles, 
brought new insight into what the representational units of such ontologies actually denote. 
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The goal of the European Union funded ReMINE project is to develop a prediction, detection 
and monitoring platform for managing risks against patient safety (RAPS). This involved the 
development of an ontology by carrying out three types of activities. First was the description 
of the domain of adverse events as cognized by human beings. This formed the basis for a 
taxonomy organized in ways familiar to clinicians [1]. The taxonomy then served as input for 
the two other types of activities: the development of (1) a purpose-independent domain 
ontology for adverse events, and (2) a series of application ontologies derived from the former 
to support applications for guideline checking and protocol monitoring in the three specific 
areas covered by the ReMINE pilot sites: stroke management, emergency medicine and 
obstetrics.   
In this paper, we report on our efforts to design the upper level parts of the domain 
ontology in such a way that it remains faithful to both the cognitive perspective adhered to by 
clinicians, terminologists, and software engineers on the hand and the principles for high 
quality ontology development as advanced under a realist agenda on the other hand. 
2 Objectives 
2.1 Detect confusions and clarify distinctions in adverse event terminology 
The goal of the domain ontology is to support the management of a repository populated 
through input from the ReMINE pilot sites that keeps track of incidents involving patients that 
can be qualified as ‘adverse events’.  The cognitive engineering position defended in the 
ReMINE project [1] describes an adverse event as ‘an incident (a perdurant) that occurred to 
a patient during the past, that is documented in a database of adverse events and that is an 
expectation of some future happening that can be prevented’ [2]. This definition adds yet 
another aspect to the variety of ways the term ‘adverse event’ is already defined in the 
literature, superordinate terms frequently used being ‘reaction’, ‘effect’, ‘event’, ‘problem’, 
‘experience’, ‘injury’, ‘symptom’, ‘illness’, ‘occurrence’, ‘change’, and even ‘something’, 
‘act’, ‘observation’ and ‘term’, the latter four being the result of applying flawed 
terminological theories which rest on a confusion between an entity and an observation or 
record thereof [3]. This multitude of definitions is brought about by the many organizations 
and initiatives that have set themselves the noble goal of reducing the occurrence of adverse 
events, especially since the year 2000, when the Institute of Medicine published its report To 
Err is Human: Building a Safer Health System [4]. Table 1 contains a small selection of 
adverse event definitions by authoritative sources, drawn from a larger collection that we 
composed for our work in [5]. A first objective for the ontology was thus to bring clarity to 
the terminological wilderness that grew out of all these efforts. Problems arise not only 
because of differences amongst initiatives in terms of scope, health care settings involved, 
jurisdictions, and objectives – the consequence being that definitions resulting from such 
efforts are not applicable outside the original boundaries – but also because of a widespread 
failure to adopt sound ontological and terminological principles in analysing and conveying 
what is relevant. Our objective here is to show that by using the right ontological approach, a 
data repository built on a suitably modified version of the ReMINE definition can not only be 
used to detect and monitor adverse events, but also to advance the state of the art towards the 




Table 1. Adverse event related definitions from authoritative sources 
ID Term Definition Source Ref. 
D1 adverse drug 
event (adverse 
drug error)  
Any incident in which the use of a medication (drug or 
biologic) at any dose, a medical device, or a special 
nutritional product (for example, dietary supplement, infant 
formula, medical food) may have resulted in an adverse 
outcome in a patient. 
JTC [37] 
D2 adverse drug 
experience 
any adverse event associated with the use of a drug in 
humans, whether or not considered drug related, including 
the following:  
 an adverse event occurring in the course of the use 
of a drug product in professional practice;  
 an adverse event occurring from drug overdose 
whether accidental or intentional;  
 an adverse event occurring from drug abuse;  
 an adverse event occurring from drug withdrawal; 
and  
 any failure of expected pharmacological action. 
FDA [38] 
D3 adverse drug 
reaction 
an undesirable response associated with use of a drug that 
either compromises therapeutic efficacy, enhances toxicity, 
or both. 
JTC [37] 
D4 adverse event an observation (i.e. an act of recognizing and noting a fact 
or an occurrence of an event of interest) of a change in the 
state of a subject assessed as being untoward by one or 
more interested parties within the context of a protocol-
driven research or public health. 
BRIDG [33] 
D5 adverse event an event that results in unintended harm to the patient by an 
act of commission or omission rather than by the 
underlying disease or condition of the patient 
IOM [39] 
D6 adverse event any unfavourable and unintended sign (including an 
abnormal laboratory finding), symptom, or disease 
temporally associated with the use of a medical treatment or 
procedure that may or may not be considered related to the 
medical treatment or procedure  
NCI [40] 
D7 adverse event any untoward medical occurrence in a patient or clinical 
investigation subject administered a pharmaceutical product 
and which does not necessarily have to have a causal 
relationship with this treatment 
CDISC [41] 
D8 adverse event  an untoward, undesirable, and usually unanticipated event, 
such as death of a patient, an employee, or a visitor in a 
health care organization. Incidents such as patient falls or 
improper administration of medications are also considered 
adverse events even if there is no permanent effect on the 
patient. 
JTC [37] 
D9 adverse event an injury that was caused by medical management and that 
results in measurable disability. 
QUIC [42] 
D10 adverse event an incident (a perdurant) that occurred to a patient during 
the past, that is documented in a database of adverse events 








2.2 Identify RAPS information in electronic health record systems 
Adverse events, whatever the definition applied, occur primarily in relation to diagnostic or 
therapeutic procedures. Information about the context of these events can thus be found in the 
disease history of a patient as documented in electronic health records (EHRs), insofar they 
are available and adequately used. EHR systems, however, do not come standardly with 
background knowledge and corresponding algorithms that are able to infer whether reported 
signs and symptoms are to be considered adverse events, let alone could have been prevented 
or require mitigation procedures. The ReMINE solution here is to exploit a data annotation 
application which allows a RAPS manager to annotate clinical data as being indicative for an 
adverse event. Over time, the annotations will constitute a knowledge base – a ‘RAPS 
repository’ – that can be used to suggest appropriate annotations automatically. This requires 
an adequate formal representation of the adverse event domain which is compatible with 
clinical terminologies and ontologies used in EHRs. Achieving this was the second objective 
of our endeavor. 
2.3 Ensure compatibility with the OBO Foundry framework 
Many of the ontologies being employed in specific life science disciplines and in associated 
clinical specialisms are still built by groups working independently or with no resort to 
common ontological standards. Increasingly, one or other version of description logic such as 
OWL DL is being used in their development. However, the use of a logical representation 
language is clearly not enough to ensure high quality of an information resource [6], and even 
ontologies employing the same formal language are often not combinable into a single 
resource because of multiple incompatibilities between the ways this language is used by 
different groups to express biological or clinical information. [7]  
 The goal of the OBO (Open Biomedical Ontologies) Foundry is to counter such 
tendencies by promoting the creation of a single, expanding family of ontologies designed to 
be interoperable and logically well-formed and to incorporate accurate representations of 
biological reality by adhering to a set of common principles [8], of which the most important 
for our purposes are: 
(1) that terms and definitions should be built up compositionally out of component 
representations taken either from the same ontology or from other, more basic, feeder 
ontologies;  
(2) that ontologies should use upper-level categories drawn from Basic Formal Ontology 
[9] together with relations unambiguously defined according to the pattern set forth in 
the OBO Relation Ontology [10];  
(3) that for each domain there should be convergence upon exactly one Foundry ontology 
[11].  
Following these principles was the third objective of our effort. 
3 Material and methods 
We based our work on three collections of terms that we obtained from the ReMINE pilot. We 
further used the results of our analysis conducted on a number of distinct and mutually 
incompatible adverse event definitions found in the literature [12]. 
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 We used as feeder ontologies the Basic Formal Ontology (BFO) [13], the Foundational 
Model of Anatomy [14], and preliminary versions of three ontologies under development: the 
Disease and Diagnosis components of the Ontology of Biomedical Investigations which now 
is distributed as the Ontology for General Medical Science [15], the Information Artifact 
Ontology [16] and the Ontology for Mental Health [17]. As further required by the Foundry, 
we used relations that are unambiguously defined according to the pattern set forth in the 
OBO Relation Ontology (RO) [10].  
 In light of the use of the domain ontology for the representation of adverse events that 
actually occurred and therefore are registered in a database, we also applied the principles of 
Referent Tracking (RT) [18]. Whereas BFO – and ontologies in general – focus on what is 
generic (types), RT focuses on what is specific (instances). 
3.1 Basic Formal Ontology 
Basic Formal Ontology (BFO) is a framework encapsulating best practices in ontology 
development that underlies all OBO Foundry Ontologies [8, 19]. 
BFO has a realist orientation based on the view that terminologies and ontologies are to be 
aligned not on ‘concepts’ but rather on entities in reality [20]. Central to this view are three 
assumptions.  
 The first is that biological reality exists objectively in and of itself, i.e. independently of 
the perceptions or beliefs or theories of cognitive beings. Thus not only do a wide variety of 
entities exist in reality (human beings, hearts, bacteria, disorders, ...), but also how these 
entities relate to each other – that certain hearts are parts of human beings, that certain bacteria 
cause disorders in human beings  – is not a matter of agreements made by scientists but rather 
of objective fact. 
 The second assumption is that reality is accessible to us and that its structure can be 
discovered: it is scientific research that allows human beings to find out what entities exist and 
what relationships obtain between them.  
The third assumption is that an ontology should mirror its corresponding domain of reality. 
Thus an important aspect of the quality of an ontology is determined by the degree to which 
not merely its individual representational units – i.e. any symbolic representation (a code, a 
character string, an icon, …) which denotes a portion of reality and which is not constructed 
out of smaller parts which play a similar denoting role [21] – correspond to entities in reality 
but also the structure according to which these units are organized mimics the corresponding 
structure of reality. Realism-based ontology development was introduced into biomedical 
informatics some fifteen years ago as a means of detecting and avoiding the systematic 
mistakes characteristic of concept-based terminologies [22-26], mistakes which are not 
eliminated through the use of description logics or similar computational devices [27]. 
BFO acknowledges only those entities which exist in reality, and rejects all types of putative 
entities postulated merely as artifacts of specific logical or computational frameworks. The 
corresponding logical and computational artifacts themselves, however, are indeed accepted 
as part of reality. BFO captures a small number of basic categories into which the entities in 
reality are divided, thereby distinguishing, at the highest level of its organisation:  
(1) particulars such as Werner Ceusters from universals such as HUMAN BEING, 
(2) continuants such as Werner Ceusters’ heart from occurrents of which processes such 
as the beating of Werner Ceusters’ heart are the most salient,  
(3) independent entities such as Werner Ceusters’ heart from dependent entities such as 
the function of Werner Ceusters’ heart. 
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Dependent entities are such that they cannot exist – in the ontological rather than biological 
sense – without some instance of the category independent entity.  
BFO also distinguishes three major families of relations between entities in the categories just 
distinguished:  
(1) <p, p>-relations: from particular to particular (for example: Werner Ceusters’ s brain 
being part of Werner Ceusters, Werner Ceusters’ writing of this paper being a part 
of Werner Ceusters’ life);  
(2) <p, u>-relations: from particular to universal (for example: Werner Ceusters being an 
instance of HUMAN BEING);  
(3) <u, u>-relations: from universal to universal (for example: HUMAN BEING being a 
subkind of ORGANISM) [10]. 
Relations involving a continuant particular are time-indexed: Werner Ceusters’ brain is part 
of Werner Ceusters since the formation of his brain, whereas in his early developmental 
stages, he could do unproblematically without one. 
3.2 Referent Tracking 
Referent tracking has been introduced as a new paradigm for entry and retrieval of data in the 
Electronic Health Record (EHR) to avoid the multiple ambiguities that arise when statements 
in an EHR refer to disorders, lesions and other entities on the side of the patient exclusively 
by means of generic terms from a terminology or ontology [28]. Referent tracking avoids such 
ambiguities by introducing IUIs – Instance Unique Identifiers – for each numerically distinct 
entity that exists in reality and that is referred to in statements in a record. As ontologies serve 
integration of information at the level of universals and defined classes which particulars 
instantiate or are members of, so referent tracking serves integration of information at the 
level of these particulars themselves, which, if they are catered for at all in current electronic 
health record systems, are represented in heterogeneous and unstable ways. 
 Drawing on this framework, we have proposed a calculus for use in quality assurance of 
the complex representations created for clinical or research purposes, for example in coding of 
clinical trial data [29]. This calculus is based on a distinction between three levels [21]:  
(1) the level of reality (for example, in the medical domain, the reality on the side of the 
patient);  
(2) the cognitive representations of this reality for example as embodied in observations 
and interpretations on the part of clinicians and others;  
(3) the publicly accessible concretizations of these cognitive representations in artifacts of 
various sorts, of which ontologies and terminologies and Electronic Health Records 
are examples.  
4 Results 
The results described here build further upon and improve the results presented in two earlier 
publications [12, 30]. Work reported on in [12] was carried out before the Ontology of 
General Medical Science was initiated which required a post-hoc alignment of the 
representational units then proposed. The results presented in [30] were obtained on the basis 




Table 2. Upper level of the representations in the ReMINE Domain Ontology  
Term Category Description 
REPRESENTATION L2/3-DC [RT] CONTINUANT which is the bearer of an INFORMATION CONTENT 
ENTITY 
  REFERRING 
  REPRESENTATION 
L2/3-DC [RT] REPRESENTATION which is intended and believed to denote some 
portion of reality and which succeeds in doing so. 
  NON-REFERRING 
  REPRESENTATION 
L2/3-DC [RT] REPRESENTATION which, for whatever reason, fails to denote 
something. 
  UNRECOGNIZED 
  NON-REFERRING 
  REPRESENTATION 
L2/3-DC [RT] NON-REFERRING REPRESENTATION which, although non-referring, 
is intended and believed to have a referent. 
  RECOGNIZED 
  NON-REFERRING 
  REPRESENTATION 
L2/3-DC [RT] NON-REFERRING REPRESENTATION which was once intended and 
believed to have a referent, but which, as a result of advances in 
knowledge, is no longer believed to do so. 
  OBSERVATION L2/3-DC [RT] REPRESENTATION of a portion of reality resulting from an act of 
perception (i.e. from an act of observing) 
  DIAGNOSIS L2/3-DC REPRESENTATION asserting a particular to be the instance of some 
universal or member of some class resulting from an INTERPRETIVE 
PROCESS that has as input one or more OBSERVATIONS about that 
particular 
    HARM DIAGNOSIS L2/3-DC [AEO] REPRESENTATION resulting from a HARM ASSESSMENT and 
involving a conclusion to the effect that a certain PROCESS is or is not a 
HARM
      POSITIVE HARM 
      DIAGNOSIS 
L2/3-DC [AEO] HARM DIAGNOSIS involving a conclusion that a certain PROCESS
is a HARM
    DISEASE DIAGNOSIS L2/3-DC [OGMS:DIAGNOSIS] REPRESENTATION that (1) asserts the presence of an 
instance of DISEASE in a given ORGANISM and (2) results from an 
INTERPRETIVE PROCESS that has as input a CLINICAL PICTURE of that 
ORGANISM





Table 3. Upper level of the independent continuants in the ReMINE Domain Ontology 
INDEPENDENT 
CONTINUANT 
L1-U [BFO] CONTINUANT in which other entities inhere and which itself 
cannot inhere in anything.  
   SITE L1-U [BFO] INDEPENDENT CONTINUANT consisting of a characteristic spatial 
shape in relation to some arrangement of other continuant entities and of 
the medium which is enclosed in whole or in part by this characteristic 
spatial shape. 
    HEALTHCARE 
    FACILITY 
L1-DC MATERIAL ENTITY in which under normal circumstances ACTS OF CARE 
are performed 
  MATERIAL ENTITY   L1-U [BFO] INDEPENDENT CONTINUANT that is spatially extended and whose 
identity is independent of that of other entities and can be maintained 
through time. 
    ANATOMICAL  
    STRUCTURE 
L1-DC [FMA] MATERIAL ENTITY that is part of an ORGANISM that has been 
generated by the coordinated expression of the ORGANISM’s own 
structural genes 
      MENTAL HEALTH- 
      RELATED 
      ANATOMICAL 
      STRUCTURE 
L1-U [OMH] ANATOMICAL STRUCTURE in which there inheres the 
DISPOSITION to be the agent of a MENTAL 
    RAPS REPOSITORY L3-DC [AEO] MATERIAL ENTITY  formed-by DENOTATORS that denote
PROCESSES IN THE CONTEXT OF CARE and are the subject of a 
POSITIVE HARM DIAGNOSIS
    OBJECT L1-U [BFO] MATERIAL ENTITY  that is spatially extended, has an external 
boundary that is maximally self-connected and possesses an internal 
unity 
      ORGANISM L1-U ANATOMICAL STRUCTURE which is an individual member of a species  
        HUMAN BEING L1-U [FMA] ORGANISM which is an individual member of the human species 
          CAREGIVER L1-DC HUMAN BEING in which there inheres a CAREGIVER ROLE  
          SUBJECT OF CARE L1-DC HUMAN BEING undergoing ACTS OF CARE 
    BODILY COMPONENT L1-DC [OGMS] MATERIAL ENTITY within or on the surface of an ORGANISM, 
including ANATOMICAL STRUCTURES, body flora, pathogens, toxins, and 
their combinations 
    DISORDER L1-DC [OGMS] A combination of BODILY COMPONENTS of or in an ORGANISM
(1) that is not part of the life plan for an ORGANISM of the relevant type 
(thus aging or pregnancy are not clinically abnormal), (2) that is causally 
linked to an elevated risk of pain or other feelings of illness or of death 
or dysfunction on the part of the organism, and (3) that it is such that this 
elevated risk exceeds a certain threshold level. 
    MATERIAL 
    REPRESENTATION 
L3-DC [RT] MATERIAL ENTITY  which is a REPRESENTATION 
      DENOTATOR L3-DC [RT] MATERIAL REPRESENTATION denoting a portion of reality 
        ADVERSE EVENT 
        DENOTATOR 
L3-DC [AEO] DENOTATOR denoting a RAPS EVENT 




Table 4. Upper level of the dependent continuants in the ReMINE Domain Ontology 
DEPENDENT 
CONTINUANT 
L1-U [BFO]  CONTINUANT that is dependent on an INDEPENDENT CONTINUANT
  GENERICALLY   
  DEPENDENT 
  CONTINUANT 
L1-U [BFO]  DEPENDENT CONTINUANT that is dependent on one or other 
INDEPENDENT CONTINUANT  
    INFORMATION 
    CONTENT ENTITY 
L2/3-U [IAO]  GENERICALLY  DEPENDENT CONTINUANT which is about a portion 
of reality 
  SPECIFICALLY   
  DEPENDENT 
  CONTINUANT 
L1-U [BFO]  DEPENDENT CONTINUANT that during its entire existence is 
dependent on at least one specific INDEPENDENT CONTINUANT 
    ANATOMICAL 
    STRUCTURE 
    INTEGRITY 
L1-U SPECIFICALLY DEPENDENT CONTINUANT of an ANATOMICAL STRUCTURE
deviation from which would bring it about that the ANATOMICAL 
STRUCTURE in which it inheres would either (1) itself become 
dysfunctional or (2) cause dysfunction in another ANATOMICAL 
STRUCTURE  
    COGNITIVE 
    REPRESENTATION 
L2-U [OMH] SPECIFICALLY DEPENDENT CONTINUANT of an ANATOMICAL 
STRUCTURE which yields this structure to be a REPRESENTATION 
      INTENTION L2-U [OMH] COGNITIVE REPRESENTATION in an ORGANISM about parts of the 
LIFE of that ORGANISM that motivates that ORGANISM to participate in 
some PROCESS  
        CARE INTENTION L2-DC INTENTION in a CAREGIVER that motivates him or her towards an ACT 
OF CARE
    REALIZABLE ENTITY L1-U [BFO]  SPECIFICALLY DEPENDENT CONTINUANT that inheres in a 
CONTINUANT and is not exhibited in full at every time in which it inheres 
in it. The realization of a REALIZABLE ENTITY is a PROCESS that occurs 
under certain circumstances.
      ROLE L1-U [BFO]  REALIZABLE ENTITY whose realization brings about some result 
or end that is not essential to a CONTINUANT in virtue of the kind of thing 
that it is. 
        CAREGIVER ROLE L1-DC ROLE inhering in a HUMAN BEING mandated to be the agent of ACTS OF 
CARE
      DISPOSITION L1-U [BFO] REALIZABLE ENTITY inhering in an INDEPENDENT CONTINUANT
that under specific circumstances and in conjunction with the laws of 
nature becomes realized in a PROCESS in which the INDEPENDENT 
CONTINUANT participates
        DISEASE L1-U [OGMS] DISPOSITION (1) to undergo PATHOLOGICAL PROCESSES that (2) 
exists in an ORGANISM because of one or more DISORDERS in that 
ORGANISM
          UNDERLYING 
          DISEASE 
L1-DC the DISEASE inhering in the SUBJECT OF CARE which is part of what 





Table 5. Upper level of the process in the ReMINE Domain Ontology 
HISTORY L1-U [RT] PROCESS formed by PROCESSES in which a CONTINUANT
participates or has participated 
  LIFE L1-U [RT] HISTORY OF an ORGANISM 
BODILY PROCESS L1-U [OGMS] PROCESS in which at least one BODILY COMPONENT of an 
ORGANISM or the ORGANISM as a whole participates 
  COGNITIVE PROCESS L1-U [OMH] BODILY BROCESS which brings into being, sustains or destroys a 
COGNITIVE REPRESENTATION 
    INTERPRETIVE 
    PROCESS 
L1-U [OMH] COGNITIVE PROCESS which brings into being, sustains or 
destroys COGNITIVE REPRESENTATIONS on the basis of an OBSERVATION 
  PATHOLOGICAL 
  PROCESS 
L1-U [OGMS] BODILY PROCESS that is a manifestation of a DISORDER 
  ANATOMICAL 
  STRUCTURE 
  CHANGE 
L1-DC BODILY PROCESS involving a change in an ANATOMICAL STRUCTURE 
PROCESS IN THE 
CONTEXT OF CARE 
L1-DC PROCESS which is part of the HISTORY of a HEALTHCARE FACILITY, or 
of the LIFE of a CAREGIVER insofar this PROCESS is executed under the 
mandate associated with his CAREGIVER ROLE 
  ACT OF CARE L1-DC PROCESS IN THE CONTEXT OF CARE (1) which has as agent a 
CAREGIVER and (2) as (passive) participant a SUBJECT OF CARE, and 
(3) is motivated by an UNDERLYING DISEASE and a CARE INTENTION 
RAPS EVENT L1-DC [AEO] PROCESS denoted-by a DENOTATOR in a RAPS REPOSITORY
HARM L1-DC [AEO] PROCESS resulting in an expansion in the range of circumstances 
of the sort occurring in the HISTORY of an INDEPENDENT CONTINUANT
under which that CONTINUANT would participate in PROCESSES
involving some sort of loss or detriment, whether physically, 
functionally, socially, economically, etc. 
  BODILY HARM L1-DC [AEO] HARM consisting of a change in the STRUCTURE INTEGRITY of 
an ANATOMICAL STRUCTURE bringing about a change in the range of 
circumstances under which the ANATOMICAL STRUCTURE would become 
dysfunctional or cause dysfunction in another structure 
PREVENTION L1-DC PROCESS resulting in a decrease in the range of circumstances of the sort 
occurring in the HISTORY of a CONTINUANT under which that 
CONTINUANT would participate in PROCESSES involving some sort of 
loss or detriment, whether physically, functionally, socially, 
economically, etc. 
MITIGATION L1-DC [AEO] PREVENTION carried out in response to a HARM 
HARM ASSESSMENT L1-DC [AEO] INTERPRETIVE PROCESS to determine whether another PROCESS is 





4.1 Core representational units 
Tables 2 to 5 contain those representational units (RU) of the upper level part of the ReMINE 
ontology which are sufficient to represent the various configurations that may obtain between 
the occurrence of an incident, whether that incident involves some harm, whether it has been 
recognized as such by some cognitive agent, and whether it has been reported upon in the 
ReMINE adverse event database. For each RU we provide a term, a category, and a textual 
description.  
 The RUs are organized in a subsumption hierarchy: within each table we start with the 
most generic term for respectively representations (Table 2), independent continuants (Table 
3), dependent continuants (Table 4) and processes (Table 5). Less generic terms are indented 
towards the right. 
 The categories shown in the second column of each of these tables are formed on the basis 
of two criteria. The first concerns whether the specific entities – ‘particulars’ in BFO’s 
terminology [21] – are a matter of (L1) first-order reality such as a disorder in a specific 
patient, (L2) beliefs or cognitive representations about portions of first-order reality on the 
side of a cognitive being, for instance a diagnosis formed by a clinician, or (L3) some durable 
representation of a first- or second-order entity (e.g. a statement in some record that the 
patient suffers from an allergy). The second criterion is whether the particulars are instances 
of a universal (indicated by ‘U’) or members of a defined class (‘DC’), the latter being 
defined as a collection of particulars that share at least one characteristic (e.g. being located in 
Buffalo) that is relevant in some context [21].  
 For terms and phrases used in the descriptions shown in the third column of each of these 
tables, we used the following typographical conventions: (1) terms that express relationships 
are printed in bold, (2) terms borrowed from the feeder ontologies or referent tracking are in 
SMALL CAPS, (3) terms introduced in the ReMINE ontology are printed in bold SMALL CAPS. 
Terms printed in italic SMALL CAPS are further defined in the originating feeder ontology but 
for reasons of space and relevance not in this paper. 
 The descriptions for terms printed in SMALL CAPS are preceded by a label between square 
brackets that indicates the provenance of the term: Basic Formal Ontology (BFO), Ontology 
of General Medical Science (OGMS), Information Artifact Ontology (IAO), Foundational 
Model of Anatomy (FMA), Ontology of Mental Health (OMH), and Referent Tracking (RT). 
Newly introduced terms (22 terms) whose descriptions are preceded by ‘[AEO]’ are intended 
to become part of an Adverse Event Ontology (9 terms) which is independent of the ReMINE 
Ontology and should become part of the OBO Foundry. Terms which are not preceded by a 
label (13 terms), as well as the terms preceded by ‘[RT]’, should find their way to other 
ontologies in the OBO Foundry family. 
4.2 Examples of use 
4.2.1 The place of ‘adverse events’ 
The representational units for the core classes identified above can be used to represent all 
possible portions of reality which feature entities that can be referred to by means of the term 
‘adverse event’ under any of the definitions listed in Table 1. As an example, Table 6 lists the 
particulars and relationships involved in a case in which a patient born at time t0 undergoing 
anti-inflammatory treatment and physiotherapy since t2 for an arthrosis present since t1 
develops a stomach ulcer at t3.  
 This table thereby provides an example of an adverse event case analysis of the sort that is 
made possible by the framework here presented. The relationships employed in this table are 
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drawn from [10, 31]. We preserve the formatting conventions proposed in [10], except that we 
pick out particulars using bold italic. We introduce the primitive is_about relation holding 
between a representational unit and the entity in reality about which this unit contains 
information at a certain time. We further take certain shortcuts in our representation of the 
temporal relationships involved in such an analysis, by simply stating for example that t0 
earlier t1 earlier t2 earlier t3. 
 
Table 6. Example of an adverse event case analysis 
IUI Particular description Relationships 
#1 the patient who is treated #1 member_of SUBJECT OF CARE since t2 
#2 #1’s treatment #2 member_of ACT OF CARE 
#2 has_participant #1 since t2 
#2 has_agent #3 since t2 
#3 the physician responsible for #2 #3 member_of CARE GIVER since t2 
#4 #1’s arthrosis #4 member_of UNDERLYING DISEASE since t1 
#5 #1’s anti-inflammatory treatment  #5 part_of #2 
#5 member_of ACT OF CARE 
#6 #1’s physiotherapy #6 part_of #2 
#6 member_of ACT OF CARE 
#7 #1’s stomach #7 part_of #1 since t2 
#7 instance_of ANATOMICAL STRUCTURE since t2 
#8 #7’s structure integrity #8 instance_of ANATOMICAL STRUCTURE INTEGRITY since t0 
#8 inheres_in #7 since t0 
#9 #1’s stomach ulcer #9 part_of #7 since t3 
#9 instance_of DISORDER since t3 
#10 coming into existence of #9 #10 has_participant #9 at t3 
#10 instance_of BODILY PROCESS 
#11 change brought about by #9 #11 has_agent #9 since t3 
#11 has_participant #8 since t3 
#11 instance_of HARM 
#12 noticing the presence of #9 #12 has_participant #9 at t3+x 
#12 has_agent #3 at t3+x 
#12 instance_of COGNITIVE PROCESS 
#13 cognitive representation in #3 about 
#9 
#13 is_about #9 since t3+x 
#13 instance_of COGNITIVE REPRESENTATION since t3+x 
 
 We also allow for temporal annotations additional to those described in [10], at the same 
time remaining faithful to EN 12388:2005: Health Informatics – Time Standards for 
Healthcare Specific Problems [32]. 
 Under the proposed scenario, #10, i.e. the appearance of #9, would (modulo the wide 
variation in interpretations that can be given to the majority of the definitions found) qualify 
as an adverse event as defined by the Institute of Medicine (definition D5). 
However, for definition D9, it would rather be #9 itself that would so qualify, while for D4, 
the definition of ‘adverse event’ proposed by the BRIDG consortium [33], it would be either 
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#12 or #13. The counterintuitive nature of the latter case has its roots in certain conflations in 
the HL7 RIM [34], by which BRIDG is heavily inspired. 
4.2.2 Building a RAPS repository 
ReMINE’s pragmatic definition for the term ‘adverse event’ (D10 in Table 1) provides useful 
information that can easily be understood by human beings, but that can not be formally 
defined in a way that allows unambiguous interpretation by software agents. This is for 
several reasons.  First, there is nothing in reality that exhibits all the listed features 
simultaneously. Clearly, nothing that happened in the past (an occurrent in   
 BFO’s terminology, which is a synonym for ‘perdurant’) can be an expectation (a cognitive 
continuant).  
 Second, the pragmatic definition does not explicitly specify what sorts of incidents are to 
be considered as adverse events. Under one reading, one could assume that an incident 
becomes an adverse event by the mere fact of being reported ‘in a database of adverse events’. 
But that – if applied incautiously – would violate the principle that the past cannot be 
changed: something which is not an adverse event at the time it happens, can not become one 
afterwards. Further questions raised by this definition are, accordingly: who has the authority 
to add reports, what criteria are used by that authority, how to deal with false positives and 
negatives? 
 For the envisioned RAPS repository to be able to represent reality faithfully and to enable 
use of its data to advance the state of the art in adverse event management, the system should 
be set up in such a way that it can accommodate annotations for incidents separately from 
beliefs about whether these incidents are adverse events, and in such a way that adequate 
quality control measures are put into place. How to do so, is demonstrated in Table 7 which is 
set up in a similar way as Table 6. It represents a situation in which an incident (#1) that 
happened at time t2 to a patient (#2) after some intervention (#3 at t1) is judged at t3 to be an 
adverse event, thereby giving rise to a belief (#4) about #1 on the part of some person (#5, a 
caregiver as of time t6). Then applying ReMINE’s definition for adverse event requires the 
introduction (at t4) of an entry (#6) to that effect in the database (#7, installed at t0). Using the 
core representational units discussed above and a syntax as in [10] expanded with the 
temporal representations standardized in CEN EN12388 [32], one can then make the 
assertions listed in Table 7.  
 
 
Table 7. Fragment of a RAPS repository 
1. #3 instance_of ACT OF CARE 9. #4 inheres_in #5 since t3
2. #3 has_participant #2 at t1 10. #5 member_of CAREGIVER since t6 
3. #2 member_of SUBJECT OF CARE at t1 11. t6 earlier t1 
4. #1 instance_of PROCESS 12. #7 instance_of RAPS REPOSITORY since t0 
5. #1 has_participant #2 at t2 13. #6 instance_of ADVERSE EVENT DENOTATOR since t4 
6. t1 earlier t2 14. #6 part_of #7 since t4 
7. #4 member_of POSITIVE HARM 
DIAGNOSIS since t3 
15. #6 is_about #1 





5.1 A common ground for adverse event definitions  
Already a very superficial analysis of the definitions in Table 1 applying the analytical 
principles just sketched demonstrates that the question “What are adverse events?” cannot be 
answered directly, but needs to be reformulated as “What might the author of a particular 
sentence containing the phrase ‘adverse event’ be referring to when he uses that phrase?”. 
Indeed, the authors of the listed definitions must have had very distinct entities in mind: we 
cannot imagine even one single example of an entity which would be such that, were it placed 
before these authors, they would each in turn be able to point to it while the first would say – 
faithfully and honestly – “that is an observation” (definition D4), the second: “that is an 
injury” (definition D9), the third: “that is a laboratory finding” (definition D6), and so on. 
Clearly, nothing which is an injury can be a laboratory finding, although, of course, laboratory 
findings can aid in diagnosing an injury or in monitoring its evolution. Similarly, nothing 
which is a laboratory finding, can be an observation, although, of course, some observation 
must have been made (by either a human being or a device) if we are to arrive at a laboratory 
finding. 
 However, because all the authors of the mentioned systems use the term ‘adverse event’ in 
some context for a variety of distinct entities, and because these contexts look quite similar – 
in each of them, more or less the same sort of entities seem to be involved – there is some 
common ground (some portion of reality) which is such that the entities within it can be used 
as referents for the various meanings of ‘adverse event’.  
5.2 Classifying adverse event related entities in terms of the three levels of reality 
The definitions for the term ‘adverse event’ and for other closely related terms differ amongst 
themselves in that they require a representation which resorts to one, two or all three levels of 
reality as described above. Definition D9 is an example in which all terms refer to level 1 
entities: ‘injury’, ‘medical management’, ‘measurement’ and ‘disability’, when used in the 
context of a specific patient that may or may not have experienced an adverse event, all 
denote existing entities on the side of that particular patient and his environment, and are not 
about something else: these terms thus denote level 1 entities. D2, in contrast, requires 
bringing level 2 and perhaps even level 3 entities into the picture, and this because of the 
clause ‘any failure of expected pharmacological action’. Expectations can only be raised by a 
cognitive being and are part of the cognitive representation this cognitive being has 
constructed about the first order reality which forms his environment. Thus, in this 
interpretation of D2, i.e. if the expectation concerning the pharmacological action is ‘in the 
mind’ of the particular clinician assessing whether the patient has an adverse drug experience, 
D2 involves a level 2 entity. However, if this expectation is something which is part of 
‘general knowledge’ or belongs to the ‘state of the art’, then we are dealing with an additional 
level 3 entity: in order for the clinician assessing the case to have access to that ‘general 
knowledge’, it must have been concretized in some enduring fashion, for example in a manual 
or textbook. 
5.3 Lack of clarity in definitions 
D2 exhibits a characteristic which, unfortunately, is shared by the majority of the definitions 
encountered: they lack sufficient clarity of phrasing to allow an analysis to be conducted 
unproblematically in realist terms. Often multiple interpretations can be given to one or more 
terms used within such a definition, whereby each interpretation suggests a denotation at a 
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distinct level of reality. An example is definition D3, in which the response that is described as 
being undesirable can be understood in three different ways:  
(1) as denoting something on level 1, namely a realizable entity (a disposition or tendency 
[35]), which exists objectively as an increased health risk; in this sense any event ‘that 
either compromises therapeutic efficacy, enhances toxicity, or both’ is undesirable;  
(2) as denoting something on level 2, so that, amongst all of those events which influence 
therapeutic efficacy or toxicity, only some are considered undesirable (for whatever 
reason) by either the patient, the caregiver or both; or  
(3) as denoting something relating to level 3, so a particular event occurring on level 1 is 
undesirable only when it is an instance of a type of event that is listed in some 
guideline, good practice management handbook, i.e. in some published statement of 
the state of the art in relevant matters. 
In other cases, this sort of analysis results in detecting hidden assumptions, conflations or 
even serious inconsistencies either within one definition or in the combination of several 
definitions offered by the same source. 
An example of an inconsistency within one single definition when the latter is analyzed in 
realist terms is provided by the attempt at a literal interpretation of D5, and more precisely of 
the use, there, of the term ‘act of omission’, especially if that term is taken in such a way that 
it does not denote anything which exists either now or in the past. In Referent Tracking terms, 
there would thus be nothing to which a IUI could be assigned. Indeed, while we believe that 
the phrase ‘action not taken’ is a linguistic description (level 3 entity) that can be used 
adequately and meaningfully in reporting some feature of a complex portion of reality (level 1 
entity), such a use does not yet signify that the term denotes directly some entity in that 
portion of reality. While terms of the form ‘doing something’ do have referents in first order 
reality, there are no such referents denoted by terms like ‘doing nothing’. 
5.4 Building an unambiguous RAPS repository 
This approach, which in contrast to related work reported in [3] provides an evolutionary view 
on reality, allows us to track in detail and with various kinds of subtleties how the relevant 
portions of reality and the stakeholders’ beliefs therein evolve over time. Some subtleties are 
built into the ontology. As an example, criterion (3) for ACT OF CARE excludes those processes 
whose agents are caregivers but which are not performed under the caregiver role (e.g. a 
doctor hurting a patient in a car accident on the parking lot of a care facility). Other subtleties 
come with the referent tracking approach exemplified in Tables 6 and 7. So is clinician #5 in 
the described scenario in Table 7 careful (perhaps erroneously so) not to assert that ‘#1 
member_of HARM’ (#17), although he could have done so. If his diagnosis, as expressed in 
assertion 7 in Table 7, is correct, then #17 would correspond with reality too. If, on the other 
hand, his diagnosis is incorrect, then the presence of #17 in the repository would be an error. 
However, such errors can be corrected at later stages without losing information about the 
original beliefs [36].  
 If RAPS repository #7 were faithful to reality, each member of RAPS EVENT would be a 
member of HARM. Furthermore, if #7 were locally complete, each member of HARM that 
occurred in the realm in which #7 is installed would be a member of RAPS EVENT. Many other 
assertions can be added expressing other beliefs about #1, or even beliefs about somebody 
else’s beliefs. Distinct clinicians, depending on what definition they apply, may indeed hold 
different beliefs about whether a specific incident such as #1 (1) really happened, (2) is of a 
specific sort, or (3) counts as an adverse event. They may further differ in their beliefs about 
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what caused the incident, and about how to prevent future happenings of incidents of the same 
sort in the future. Moreover, they may change their beliefs over time. 
6 Conclusion 
We have used the principles of Basic Formal Ontology (BFO), including the Relation 
Ontology (RO), and Referent Tracking (RT) as an analytical framework to study the 
ontological nature of what is denoted by the term ‘adverse event’. Our research indicates that 
this framework is adequate to serve a number of important purposes, and that, when used 
appropriately, it avoids the inconsistencies and incompatibilities inherent in other approaches. 
We further used these principles to develop an ontology and associated data annotation 
scheme for adverse event management in the ReMINE project. The three-layered structure of 
reality – what is the case, what is believed, and what is represented – as argued for in BFO, 
turns out to be essential in this domain. 
 Merging the existing ontologies, although all designed under the OBO Foundry principles, 
was not an easy task and the proposal advanced here will most likely undergo further changes. 
More work is required on the formulation of descriptions and definitions of respectively 
universals and defined classes such that both necessary and sufficient conditions for 
instantiation and membership can be specified. This is not only true for the ReMINE ontology 
as the basis for a universal Adverse Event Ontology, but also for all feeder ontologies from 
which representational units have been borrowed.  
Additional work will also include linking these ontologies to existing terminological resources 
that enjoy a broad domain coverage but suffer from formal rigor. 
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